Vimarsana
Biggest News Aggregation in the World

Page 35 - Translational Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Translational Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Translational Sciences Today - Breaking & Trending Today

New Studies Inform Best Practices for Pelvic Organ Prolapse - Vimarsana News

New Studies Inform Best Practices for Pelvic Organ Prolapse

"Approximately one in five women will undergo surgery for prolapse and/or urinary incontinence by the age of 80, which is more likely than the risk of developing breast cancer."

Mild cognitive impairment linked to decline in decision-making abilities - Vimarsana News

Mild cognitive impairment linked to decline in decision-making abilities

Mild cognitive impairment (MCI) is a form of cognitive ability loss that can precede Alzheimer's disease or other types of dementia.

Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments - Vimarsana News

Virpax Pharmaceuticals Reports 2023 Second Quarter Results and Recent Developments

Virpax® Pharmaceuticals, Inc. , a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system disorders and viral barrier... -Today at 09:04 am- MarketScreener

Resilient biomedical scientists experienced setbacks during the pandemic - Vimarsana News

Resilient biomedical scientists experienced setbacks during the pandemic

When COVID-19 presented the world with the greatest health challenge in modern history, it was biomedical scientists who stepped up to develop diagnostic testing and vaccines to slow the spread of the disease.

VUMC receives $51 million in grants to improve the efficiency of conducting clinical trials across U.S. - Vimarsana News

VUMC receives $51 million in grants to improve the efficiency of conducting clinical trials across U.S.

Researchers in the Vanderbilt Institute for Clinical and Translational Research (VICTR) have been awarded two five-year federal grants totaling $51 million to harness new and existing approaches for boosting recruitment